Trial intelligence / Profile preview

Double Icodextrin Dose in Elderly Incident CAPD Patients (DIDo study)

2011-005274-30Phase 4Completed

Sponsor
UCLouvain
Start
Apr 2012
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of icodextrin in end-stage kidney disease (ESKD), sponsored by UCLouvain. Started Apr 2012; status: completed.

02

Drugs

icodextrin
03

Conditions

end-stage kidney disease (ESKD)

Beyond the preview

Go deeper on 2011-005274-30.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-005274-30.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call